Document Detail

Phase I/II study of high-dose rate interstitial radiotherapy for head and neck cancer.
MedLine Citation:
PMID:  1455289     Owner:  NLM     Status:  MEDLINE    
From July 1991 through December 1991, a phase I/II study of high-dose rate interstitial radiotherapy for head and neck cancer was performed to determine any acute adverse effects and mucosal reaction as well as the feasibility of this therapy. A total of seven patients with head and neck cancer (tongue: four cases; mouth floor: one case; buccal mucosa: one case; oral mucosa of lower lip: one case) were entered into this study. The dose schedule of high-dose rate interstitial radiotherapy ranged from 35 Gy/ten fractions (bid)/week to 60 Gy/ten fractions/week. No major or minor early complication was observed. Spotted mucositis appeared starting three days after the end of high-dose rate interstitial radiotherapy while confluent mucositis developed and approached a peak at ten days but disappeared by the fourth to eighth week. Early tumor responses of all patients were complete.
T Teshima; T Inoue; H Ikeda; S Murayama; S Furukawa; K Shimizutani
Related Documents :
8416879 - Predictive value of in vitro radiosensitivity parameters in head and neck cancers and c...
6190559 - Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin alone or combined w...
15083109 - Comparison of comorbidity indices for patients with head and neck cancer.
638949 - Changes in cell-mediated immunity in patients undergoing radiotherapy.
11591019 - Predictive value of the tumor oxygenation by means of po2 histography in patients with ...
8703389 - A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx.
21990399 - Eight cycles of escalated-dose beacopp compared with four cycles of escalated-dose beac...
7786259 - Hepatic artery chemotherapy for colorectal liver metastases.
21696249 - Effectiveness of entecavir in the management of acute hepatitis b developing in a patie...
Publication Detail:
Type:  Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]     Volume:  168     ISSN:  0179-7158     ISO Abbreviation:  Strahlenther Onkol     Publication Date:  1992 Nov 
Date Detail:
Created Date:  1993-01-06     Completed Date:  1993-01-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8603469     Medline TA:  Strahlenther Onkol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  617-21     Citation Subset:  IM    
Department of Radiology, Osaka University Medical School, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Brachytherapy / adverse effects*,  instrumentation
Head and Neck Neoplasms / radiotherapy*
Mouth Mucosa / radiation effects
Radiotherapy Dosage
Remission Induction
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Overestimation of severity of mitral stenosis during cardiac catheterization due to a large left atr...
Next Document:  Cancer rehabilitation in the Federal Republic of Germany--a critical review from the perspective of ...